No association between SNP309 promoter polymorphism in the MDM2 and cervical cancer in a study from northeastern Brazil

Cancer Detection and Prevention

Volumn 31, Issue 5, 2007, Pages 371-374

  de Vasconcellos Meissner, Rosely ^a   Niskier Ferreira Barbosa, Rodrigo ^a   Veríssimo Fernandes, José ^a   Medeiros Galvão, Tatiana ^a   Oliveira Galvão, Ana Flávia ^a   de Medeiros Oliveira, Gustavo Henrique ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Brazilian population; Cancer risk factor; Cervical cancer; Cervix carcinoma; DNA polymorphism; HPV; MDM2 gene; MDM2 promoter polymorphism; Primer introduced restriction analysis (PIRA) PCR; SNP309

Indexed keywords

GENE PRODUCT; PROTEIN MDM2;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; EARLY DIAGNOSIS; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

ADULT; AGE OF ONSET; BRAZIL; CARCINOMA; FEMALE; HUMANS; IMMUNOBLOTTING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MDM2; UTERINE CERVICAL NEOPLASMS;

EID: 36549021735     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.09.001     Document Type: Article

References (20)

1. Scheffner M., Wernner B.A., Huibergst J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
2. Bosch F.X., Lorincz A., Muñoz N., Meier C.J.L.M., and Shah K.V. The casual relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
3. Juven-Gershon T., and Oren M. Mdm2: the ups and downs. Mol Med 5 (1999) 71-83
4. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
5. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., et al. Single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119 (2004) 591-602
6. Bougeard G., Baert-Desurmont S., Tournier I., Vasseur S., Martin C., Brugieres L., et al. Impact of the MDM2 SNP309 and Arg72Pro polymorphism on age tumour onset in Li-Fraumeni syndrome. J Med Genet 43 (2006) 531-533
7. Sambrook J., Fritsch E.F., and Manniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1992), Cold Spring Harbor Laboratory, New York
8. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
9. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., and Wolinsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells Mol Diagnos Hum Cancer 7 (1989) 209-214
10. Bauer H.M., Yi Ting M.S., Chambers J.C., Tashiro C.J., Chimera J., Reingold A., et al. Genital human papillomavirus infection in female university students as determinated by PCR-based methods. JAMA 265 (1991) 23-30
11. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
12. Ma H., Hu Z., Zhai X., Wang S., Wang X., Qin J., et al. Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population. Cancer Lett 240 2 (2006) 261-267
13. Sanguinetti C.J., Dias Neto E., and Simpson A.J.G. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17 (1994) 915-916
14. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 1 1 (2004) 6
15. Bosch F.X., Lorincz A., Muñoz N., Meiier C.J.L.M., and Shah K.V. The casual relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
16. Lorenzato F., Ho L., Terry G., Singer A., Santos L.C., De Lucena Batista R., et al. The use of polymerase chain reaction amplification for the detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 10 (2000) 143-150
17. Harris S.L., Gil G., Robins H., Hu W., Hirshfield K., Bond E., et al. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci USA 102 45 (2005) 16297-16302
18. Alhopuro P., Ylisaukko-oja S.K., Koskinen W.J., Bono P., Arola J., Järvinen H.J., et al. The MDM2 promoter polymorphism SNP309T → G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. J Med Genet 42 (2005) 694-698
19. Campbell I.G., Eccles D.M., and Choong D.Y.H. No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer. Cancer Lett 240 2 (2006 Aug 28) 195-197
20. Hu Z., Ma H., Lu D., Qian J., Zhou J., Chen Y., et al. Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population. Int J Cancer 118 (2006) 1275-1278